Equity Profile

RYTM

Rhythm Pharmaceuticals, Inc.

Health CareBiotechnology$7.4B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Rhythm Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative treatments for rare genetic disorders related to obesity....

Key Metrics to Watch

EPS

Earnings per share will indicate the company's profitability and operational efficiency this quarter.

N/A

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

RYTM Q2-2026 Earnings Preview

Context

Company Snapshot

Rhythm Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative treatments for rare genetic disorders related to obesity. With a market cap of $7 billion, it plays a crucial role in the health care sector, especially as demand for specialized medical solutions continues to grow.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-1.49%

Avg Stock Reaction

+1.37%

Last Quarter Recap

In Q1-2026, Rhythm Pharmaceuticals reported an EPS of -$0.83, slightly beating expectations. The stock reacted positively, gaining 7.86% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's recent performance and the potential for positive surprises.

Bull Case

If Rhythm can show improved revenue and further narrow its losses, it could signal strong demand for its products and lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or shows continued losses, it could lead to a decline in investor confidence and a drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS figure be this quarter?

Given the company's history of EPS surprises, this number will be critical in shaping investor sentiment.

How is revenue trending compared to previous quarters?

Revenue growth is essential for assessing the company's market position and future potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Rhythm to narrow its losses significantly this quarter, given recent improvements in operational efficiency.

Supporting Evidence

The stock has shown resilience with a positive reaction to the last earnings surprise.

Options pricing suggests a larger move than historical averages, indicating heightened expectations.

The company's recent initiatives may not be fully reflected in current analyst estimates.

Key Risk

If EPS comes in better than -$0.70, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will indicate whether the company is on a path to profitability or continuing to struggle.

Bull Confirmed If

Achieving an EPS of -$0.70 or better would confirm the bull case.

Bear Confirmed If

An EPS worse than -$0.90 would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±11.61%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings announcement.

Options are pricing ±11.6% while RYTM has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

50.6%

Calls (900)P/C Ratio: 0.44Puts (600)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Rhythm beats expectations, history suggests a potential stock increase of around 3.24%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further clarity from management.

Miss

A disappointing report could lead to a decline of about 0.50%, reflecting investor concerns over ongoing losses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements.
2Management's commentary on market demand for their treatments.
3Insights into cost management and operational efficiency improvements.
4Guidance on expected revenue growth for the next quarter.
5Any new partnerships or collaborations that could enhance market reach.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Rhythm Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative treatments for rare genetic disorders related to obesity....

Key Metrics to Watch

EPS

Earnings per share will indicate the company's profitability and operational efficiency this quarter.

N/A

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

RYTM Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-1.49%

Avg Stock Reaction

+1.37%

Last Quarter Recap

In Q1-2026, Rhythm Pharmaceuticals reported an EPS of -$0.83, slightly beating expectations. The stock reacted positively, gaining 7.86% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic ahead of the earnings report, given the company's recent performance and the potential for positive surprises.

Bull Case

If Rhythm can show improved revenue and further narrow its losses, it could signal strong demand for its products and lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or shows continued losses, it could lead to a decline in investor confidence and a drop in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS figure be this quarter?

Given the company's history of EPS surprises, this number will be critical in shaping investor sentiment.

How is revenue trending compared to previous quarters?

Revenue growth is essential for assessing the company's market position and future potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Rhythm to narrow its losses significantly this quarter, given recent improvements in operational efficiency.

Supporting Evidence

The stock has shown resilience with a positive reaction to the last earnings surprise.

Options pricing suggests a larger move than historical averages, indicating heightened expectations.

The company's recent initiatives may not be fully reflected in current analyst estimates.

Key Risk

If EPS comes in better than -$0.70, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will indicate whether the company is on a path to profitability or continuing to struggle.

Bull Confirmed If

Achieving an EPS of -$0.70 or better would confirm the bull case.

Bear Confirmed If

An EPS worse than -$0.90 would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±11.61%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings announcement.

Options are pricing ±11.6% while RYTM has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

50.6%

Calls (900)P/C Ratio: 0.44Puts (600)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Rhythm beats expectations, history suggests a potential stock increase of around 3.24%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further clarity from management.

Miss

A disappointing report could lead to a decline of about 0.50%, reflecting investor concerns over ongoing losses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements.
2Management's commentary on market demand for their treatments.
3Insights into cost management and operational efficiency improvements.
4Guidance on expected revenue growth for the next quarter.
5Any new partnerships or collaborations that could enhance market reach.